INTRODUCTION {#S1}
============

Excitatory synaptic plasticity within the nucleus accumbens (NAc) is a substrate for adaptive motivational behavior implicated in various neuropsychiatric disease states, including addiction and depression ([@R17]). The NAc gates motivational behavior by scaling downstream access to limbic-motor centers ([@R29]). A component of this gate is formed by interneuron (IN)-embedded microcircuits, such as disynaptic feedforward inhibition, that regulate synaptic events mediating NAc output ([@R35]; [@R23]; [@R1]). Long-range glutamatergic inputs from corticolimbic structures collateralize onto GABAergic fast-spiking parvalbumin (PV)-expressing INs (PV-IN) to synchronize the activity of D1 and D2 dopamine (DA) receptor-expressing medium spiny neurons (MSNs) ([@R23]; [@R25]; [@R28]). Although GABAergic transmission at PV-IN-to-MSN synapses is a recognized regulatory element within striatal microcircuits, mechanisms regulating glutamatergic transmission onto PV-INs in the NAc remain relatively unexplored.

PV-INs in the NAc display hodological similarities to D1 and D2 MSNs, receiving glutamatergic afferents from the hippocampus, prefrontal cortex, mediodorsal thalamus, basolateral amygdala (BLA), and ventral tegmental area (VTA) ([@R23]; [@R39]; [@R28]). An important distinction between PV-INs and other striatal cell types is the selective expression of GluA2-lacking Ca^2+^-permeable AMPA receptors (CP-AMPARs) on PV-INs in drug-naive states ([@R10]; [@R39]). CP-AMPARs exhibit greater single-channel conductance, faster deactivation kinetics, and an inwardly rectifying biophysical profile ([@R16]; [@R19]). The fast-spiking, electrotonic, and synaptic properties of PV-INs allow these cells to rapidly transduce shifts in corticolimbic circuit activity into a GABAergic signal coordinating MSN output ([@R20]; [@R27]). Therefore, CPAMPAR-predominant synapses onto PV-INs in the NAc may have broad regulatory consequences on NAc circuit function ([@R26]). Indeed, potentiating synaptic strength at BLA inputs onto PV-INs in the NAc shell expedites cocaine self-administration, supporting the notion that a critical locus within NAc feedforward microcircuits is excitatory drive onto PV-INs ([@R39]).

In the present study, we investigated synaptic plasticity mechanisms at glutamatergic synapses onto PV-INs in the NAc core. We used *in vivo* behavioral pharmacology and whole-cell patch-clamp electrophysiology in cell-type-specific reporter mice. We report that NAc-specific blockade of CP-AMPARs, the basal expression of which is restricted to PV-positive cells (PV(+)-INs) and not D1 DA receptor \[D1(+)\] or D2 DA receptor \[D1(\[−\])\] MSNs, elicits a hyperlocomotor phenotype. Adapting a low-frequency stimulation (LFS) protocol that elicits long-term depression (LTD) at synapses onto D2 MSNs, we find that LFS triggers LTD of glutamatergic transmission onto PV(+)-INs by CP-AMPARs. LTD at these synapses requires Ca^2+^ influx by CP-AMPARs that evokes endocannabinoid (eCB) signaling at presynaptic cannabinoid type-1 receptors (CB~1~Rs). In addition, CP-AMPARs gate tonic CB~1~R signaling by regulating the production of anandamide (AEA). These findings elucidate a behaviorally relevant circuit element regulating the synaptic strength of PV-IN-embedded microcircuits in the NAc core.

RESULTS {#S2}
=======

CP-AMPARs Are Functionally Restricted to Glutamatergic Synapses onto PV-INs in the NAc Core {#S3}
-------------------------------------------------------------------------------------------

Fast-spiking INs, of which most contain the Ca^2+^-binding protein PV, express GluA2-lacking CP-AMPARs throughout the fore-brain ([@R10]). CP-AMPARs are glutamate-gated ion channels lacking the post-transcriptionally edited GluA2 subunit ([@R12]). Although developmentally regulated, GluA2-lacking CP-AMPARs mediate fast excitatory transmission at privileged synaptic loci within IN-embedded microcircuits ([@R10]; [@R24]). CP-AMPARs exhibit greater single-channel conductance, inward rectification, and sharp activation-deactivation kinetics that confer specialized synaptic properties ([@R31], [@R32]). To determine if PV-INs \[PV(+)-INs\] in the NAc core differ from D1(+)- and D1(−)-expressing MSNs in functional CP-AMPAR content, we prepared acute *ex vivo* brain slices from PV^Cre^-tdTomato(tdT)^*f/-STOP-fl*^ (PV^tdT^) and D1tdTomato transgenic reporter mice ([Figure 1A](#F1){ref-type="fig"}). This strategy allows PV(+) and D1(+) cells in the NAc to be visualized *ex vivo*, as described previously ([@R25]; [@R18]). To confirm that tdT(+) cells in PV^tdT^ mice were PV-INs, we performed current-clamp recordings in tdT(+) cells to determine if tdT(+) cells displayed a fast-spiking electrophysiological profile. Depolarizing current injection exceeding the action potential (AP) threshold in tdT(+) cells elicited high-frequency AP firing with short-duration waveforms and steep afterhyperpolarizations (AHPs), consistent with fast-spiking PV-INs in the NAc. In contrast, D1(+) and D1(−) MSNs in D1tdTomato mice exhibited a regular-spiking electrophysiological profile, hyperpolarized resting membrane potential (V~RMP~), and prolonged AHPs, consistent with MSN properties described previously ([Figure 1B](#F1){ref-type="fig"}; data shown: AP frequency at 350 pA, PV(+): 157.5 ± 8.7 Hz, n = 10; D1(+): 22.8 ± 1.4 Hz, n = 12; D1(−): 26.2 ± 3.5 Hz, n = 9; 1-way ANOVA, p \< 0.001).

We next obtained electrically evoked excitatory postsynaptic currents (EPSCs) in PV(+)-INs of PV^tdT^ mice and D1(+) and D1(−) MSNs of male D1tdTomato mice. AMPAR-mediated EPSCs were pharmacologically isolated by incorporating a GABA~A~ receptor (GABA~A~R) antagonist, picrotoxin (50 μM), and a NMDAR antagonist, APV (50 μM), into the artificial cerebral spinal fluid (ACSF) bath. To assess stoichiometric differences in AMPAR content at glutamatergic synapses onto PV(+)-INs relative to D1(+) and D1(−) MSNs, we examined the current-voltage (I-V) relationship of AMPAR-mediated EPSCs in each cell type. The rectification index (RI), calculated as the amplitude ratio of EPSCs obtained at −70 mV relative to +40 mV, was significantly higher in PV(+)-INs than both MSN subtypes, indicating the presence of inwardly rectifying GluA2-lacking CP-AMPARs in PV(+)-INs ([Figures 1C](#F1){ref-type="fig"}--[1E](#F1){ref-type="fig"}; RI, PV(+): 4.32 ± 0.57, n = 7; D1(+): 1.83 ± 0.30, n = 6; D1(−): 1.79 ± 0.17, n = 6; 1-way ANOVA, p = 0.002). Despite an increased RI in PV(+)-INs, we did not detect a difference in the AMPAR/NMDAR ratio between cell types ([Figure 1F](#F1){ref-type="fig"}; D1(+) A/N: 1.67 ± 0.098, n = 9; D1(−) A/N: 1.69 ± 0.269, n = 12; PV(+) A/N: 2.32 ± 0.288, n = 13; 1-way ANOVA: F(2, 31) = 2.27, p = 0.119). Bath application of a CP-AMPAR-selective AMPAR antagonist, 1-naphthylacetyl spermine (NASPM, 200 μM), also significantly decreased EPSC amplitude in PV(+)-INs without altering EPSC amplitude in D1(+) or D1(−) MSNs ([Figures 1H](#F1){ref-type="fig"} and [1I](#F1){ref-type="fig"}; NASPM, PV(+): 54.45% ± 6.57%, n = 5; D1(+): 98.68% ± 6.74%, n = 5; D1(−): 94.04% ±1.91%, n = 5; 1-way ANOVA, p \< 0.001). Furthermore, AMPAR-mediated EPSCs in PV(+)-INs exhibited significantly faster decay kinetics (t~1/2~) than D1(+) and D1(−) MSNs ([Figures 1F](#F1){ref-type="fig"}--[1J](#F1){ref-type="fig"}; t~1/2~, PV(+): 4.04 ± 0.18 ms, n = 15; D1(+): 7.35 ± 0.35 ms, n = 10; D1(−): 7.23 ± 0.50, n = 11; 1-way ANOVA p \< 0.001). The t~1/2~ of EPSCs in PV(+)-INs was increased in the presence of NASPM but was still less than the t~1/2~ of EPSCs in D1(+) and D1(−) MSNs, pointing to potential electrotonic differences in dendritic charge transfer in PV(+)-INs ([Figure 1I](#F1){ref-type="fig"}; NASPM t~1/2~, ACSF PV(+): 4.04 ± 0.18 ms, n = 15; NASPM PV(+): 5.12 ± 0.33, n = 12; p = 0.004). Consistent with our AMPAR/NMDAR measurements, spontaneous EPSC (sEPSC) amplitude did not differ between cell types, but sEPSC frequency was significantly increased in PV(+)-INs relative to D1(+) and D1(−) MSNs ([Figures 1J](#F1){ref-type="fig"}--[1L](#F1){ref-type="fig"}) (sEPSC frequency, D1(+): 1.03 ± 0.18 Hz, n = 12; D1(−): 1.20 ± 0.20 Hz, n = 13; PV(+): 7.22 ± 0.61 Hz; n = 13, 1-way ANOVA; cell effect: F(2, 35) = 79.32, p \< 0.001) (sEPSC amplitude, D1(+): −19.05 ± 1.24 pA, n = 10; D1(−): 19.26 ± 0.99 pA, n = 12; PV(+): −20.53 ± 0.95 pA, n = 12; 1-way ANOVA; cell effect: F(2, 31) = 0.571, p = 0.963). Together, these data indicate that glutamatergic synapses onto PV-INs are uniquely enriched in CP-AMPARs and exhibit distinct synaptic properties from MSNs.

Blockade of Ca^2+^-Permeable AMPARs in the NAc Core Increases Locomotor Output {#S4}
------------------------------------------------------------------------------

The functional relevance of CP-AMPAR-invigorated synapses in the NAc following drug cessation is well-documented; yet, little is known about how CP-AMPARs expressed basally regulate behavioral output ([@R38]). To determine how CP-AMPARs in the NAc control basal locomotor activity, we cannulated the dorsomedial NAc core of 8- to 12-week-old mice and microinfused selective CP-AMPAR antagonist, NASPM (5 μg/μL), or saline (SAL) prior to a 30-min open field assay (OFA) ([Figure 2A](#F2){ref-type="fig"}). Relative to SAL-infused control mice, mice infused with NASPM in the NAc core exhibited a progressive increase in locomotor activity that was greatest at the 30-min time point ([Figure 2B](#F2){ref-type="fig"}; 2-way repeated measures ANOVA \[RM-ANOVA\], p \< 0.05 at t = 20--30 min, F(1,24) = 34.34). NASPM-infused mice displayed greater total locomotor activity throughout the OFA task, indicating that CP-AMPAR-containing synapses in the NAc functionally constrain baseline locomotor output ([Figures 2B](#F2){ref-type="fig"} and [2C](#F2){ref-type="fig"}; 30-min total, SAL: 4153 ± 940.7 cm, n = 8; NASPM: 8858 ± 1503 cm, n = 9; p = 0.021).

LFS Elicits CP-AMPAR-Dependent LTD of Glutamatergic Transmission onto PV(+)-INs {#S5}
-------------------------------------------------------------------------------

PV(+)-INs receive collateralizing glutamatergic input from corticolimbic afferents that target D1(+) and D1(−) MSNs. At synapses onto D2-GFP(+) \[D1(−)\] MSNs in the NAc core, LFS (10 Hz) triggers robust LTD ([@R9]; [@R30]). To determine if LFS modulates glutamatergic synaptic strength onto PV(+)-INs, LFS was delivered locally for 5 min following a 10-min EPSC baseline obtained from PV(+)-INs. LFS elicited high-fidelity EPSCs in PV(+)-INs throughout the induction protocol ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}). LFS resulted in a persistent decrease in EPSC amplitude throughout the recording period, indicating the induction of LTD of glutamatergic synapses onto PV(+)-INs. ([Figures 3A](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}; LTD, PV(+): 54.67% ±6.79%, n = 9, p \< 0.001). We next asked whether intracellular Ca^2+^ signaling in PV(+)-INs is required for the induction of this LTD, as activity-dependent shifts in Ca^2+^ signaling underlie various forms of plasticity in the NAc ([@R9]; [@R7]). To test this possibility, we included a fast-acting Ca^2+^ chelator, BAPTA (30 mM), in the intracellular solution of the patch pipette. BAPTA completely blocked LFS-induced LTD, suggesting that a rise in intracellular Ca^2+^ in PV(+)-INs is required for LTD ([Figures 3D](#F3){ref-type="fig"} and [3I](#F3){ref-type="fig"}; BAPTA,76.37% ± 9.86%, n = 6, p = 0.032).

To begin to identify the synaptic source of Ca^2+^ triggering LTD at these synapses, we first tested the contribution of metabo-tropic glutamate receptors (mGluRs), as group I mGluRs are required for the induction of LFS-LTD at MSN synapses in the NAc core and shell. Incorporation of a pan-mGluR antagonist, LY341495 (100 μM), into the ACSF bath prior to the induction protocol failed to prevent LTD at glutamatergic synapses onto PV(+)-INs ([Figures 3F](#F3){ref-type="fig"}--[3H](#F3){ref-type="fig"}; mGluRs, 42.96% ± 8.88%, n = 6, p = 0.163). Moreover, bath application of a selective group I mGluR agonist, (*RS*)-dihydroxyphenylglycine (*RS*-DHPG, 100 μM), elicited a transient depression in EPSC amplitude at PV(+)-IN synapses that returned to baseline following drug washout, indicating a lack of group I mGluR-induced LTD at these synapses ([Figures 3G](#F3){ref-type="fig"} and [3H](#F3){ref-type="fig"}; DHPG, 100.37% ± 5.75%, n = 6, p = 0.454). These findings indicate that LFS-induced LTD of glutamatergic transmission onto PV(+)-INs is mGluR independent. To determine if LFS instead recruits postsynaptic NMDAR function, we repeated these experiments in the presence of an NMDAR antagonist, APV (50 μM). APV also failed to block LFS-induced LTD at PV(+)-IN synapses ([Figures 3I](#F3){ref-type="fig"} and [3K](#F3){ref-type="fig"}; APV, 45.34% ± 13.3%, n = 5, p = 0.232). Given that NASPM-sensitive CP-AMPARs are selectively expressed at PV(+)-IN synapses, we hypothesized that Ca^2+^ influx through CP-AMPARs contributes to the rise in intracellular Ca^2+^ necessary for LTD. To test this hypothesis, we incorporated CP-AMPAR antagonist NASPM (200 μM) into the ACSF bath for 30 min prior to establishing an EPSC baseline. Interestingly, we were unable to elicit LFS-LTD in the presence of NASPM, indicating that LTD triggered at these synapses requires CP-AMPAR-mediated Ca^2+^ entry ([Figures 3J](#F3){ref-type="fig"} and [3K](#F3){ref-type="fig"}; NASPM, 97.72% ± 7.40%, n = 6, p = 0.003).

CP-AMPARs Gate Tonic eCB Signaling through CB~1~Rs at Glutamatergic Synapses onto PV(+)-INs {#S6}
-------------------------------------------------------------------------------------------

NASPM superfusion was accompanied by a surprising reduction in the coefficient of variance (CV) and paired pulse ratio (PPR) of EPSCs recorded from PV(+)-INs, metrics which inversely correlate with presynaptic release probability ([Figures 4A](#F4){ref-type="fig"}--[4C](#F4){ref-type="fig"}; PPR ACSF: 1.44 ± 0.05, n = 22; PPR NASPM: 1.16 ± 0.07; n = 20, p = 0.001) (CV ACSF: 1.18 ± 0.16, n = 12; CV NASPM: 0.58 ±0.10; n = 9, p = 0.01). Although shifts in CV also correspond to the number of functional release sites, blockade of CP-AMPAR-predominant synapses would theoretically increase CV. Thus, we hypothesized that CP-AMPARs control a tonically active, Ca^2+^-sensitive retrograde messenger at these synapses, a probable candidate being eCBs. To determine if eCBs tonically regulate glutamatergic transmission onto PV(+)-INs by presynaptic CB~1~Rs, we first measured 50-ms PPR in the presence of a CB~1~R inverse agonist, AM251 (5 μM). Preincubation in AM251 significantly reduced PPR relative to ACSF control slices and occluded the NASPM-induced decrease in PPR, suggesting that both pharmacological manipulations involve presynaptic CB~1~R signaling ([Figures 4D](#F4){ref-type="fig"} and [4E](#F4){ref-type="fig"}; PPR AM251: 1.14 ± 0.10, n = 8, p = 0.025; PPR AM251 + NASPM: 1.07 ± 0.06, n = 9, p = 0.003; 1-way ANOVA, AM251 versus AM251+NASPM, p = 0.985). We next assessed whether AEA or 2-arachidonylglycerol (2-AG), two canonical arachidonic-acid-derived eCBs regulating synaptic strength in the NAc, mediate tonic CB~1~R signaling at this synapse ([@R11]; [@R9]; [@R14]). In slices incubated in URB597 (1 μM), an inhibitor of the AEA degradative enzyme fatty acid amide hydrolase (FAAH), PPR was significantly increased relative to ACSF control slices, whereas preincubation in DO34 (1 μM), a selective inhibitor of a 2-AG synthetic enzyme, diacylglycerol lipase (DAGL), failed to evoke a significant change in PPR ([Figures 4D](#F4){ref-type="fig"} and [4E](#F4){ref-type="fig"}; PPR URB597: 1.77 ± 0.08, n = 16, p = 0.002; PPR DO34: 1.48 ± 0.05, p = 0.998). These data provide evidence that CP-AMPARs at PV-IN synapses promote tonic CB~1~R activity mediated primarily by AEA signaling.

To assess this mechanism more thoroughly, we examined the effects of AM251 on EPSC amplitude when acutely incorporated into the ACSF bath. Following a 10-min EPSC baseline, AM251 was bath applied for a prolonged exposure period (40 min) to capture changes in EPSC amplitude. Bath application of AM251 resulted in an increase in EPSC amplitude that was accompanied by a decrease in the PPR, consistent with a presynaptic enhancement of glutamate release probability observed above ([Figures 4F](#F4){ref-type="fig"} and [4I](#F4){ref-type="fig"}; EPSCs, 128.27% ± 6.06%, n = 6, p \< 0.001; PPR baseline = 1.31 ± 0.180; PPR post-AM251 = 0.93 ± 0.17, n = 6; paired t test, p \< 0.001). If AEA signaling mediates eCB tone, preincubating slices in a FAAH inhibitor should enhance the AM251-evoked increase in EPSC amplitude. Consistent with this hypothesis, bath application of AM251 in URB597-incubated slices unmasked a significant increase in EPSC amplitude relative to baseline and control conditions ([Figures 4G](#F4){ref-type="fig"} and [4I](#F4){ref-type="fig"}; AM251 + URB: 146.63% ±5.01%, n = 6, p \< 0.001; 1-way ANOVA, AM251 versus AM251+URB, F(3,16) = 28.16, p = 0.017). Furthermore, prolonged bath application of DO34 had no effect on EPSC amplitude ([Figures 4H](#F4){ref-type="fig"} and [4I](#F4){ref-type="fig"}; DO34: 98.65% ± 5.36%, n = 6, p = 0.396). To ascertain whether CP-AMPARs contribute to the AM251-evoked increase in EPSC amplitude, we incorporated NASPM into the ACSF bath prior to AM251. NASPM completely abolished the AM251-induced increase in EPSC amplitude, corroborating our initial pharmacological findings that CP-AMPARs promote tonic eCB signaling at glutamatergic synapses onto PV(+)-INs ([Figures 4H](#F4){ref-type="fig"} and [4I](#F4){ref-type="fig"}; 91.29% ± 6.37%, n = 4, p = 0.107).

CB~1~R Signaling Mediates the Expression of LTD Triggered by CP-AMPARs at Glutamatergic Synapses onto PV(+)-INs {#S7}
---------------------------------------------------------------------------------------------------------------

Our data indicate that glutamatergic synapses onto PV(+)-INs in the NAc core are tonically regulated by eCBs. To determine if these synapses undergo phasic modes of CB~1~R-dependent plasticity, we first examined depolarization-induced suppression of excitation (DSE) ([Figure 5A](#F5){ref-type="fig"}). Following a 60-s EPSC baseline sampled at 0.2 Hz, PV(+)-INs underwent a 10-s depolarization step to +40 mV, resulting in a transient reduction in EPSC amplitude consistent with the presence of DSE ([Figures 5B](#F5){ref-type="fig"} and [5C](#F5){ref-type="fig"}; 61.92% ± 4.05%, n = 8, p \< 0.001). To ensure that DSE at these synapses reflects a Ca^2+^-dependent mobilization of eCBs, we repeated these experiments in EGTA-loaded intracellular solution to chelate depolarization-induced elevations in intracellular Ca^2+^. EGTA completely abolished the expression of DSE relative to control conditions ([Figures 5D](#F5){ref-type="fig"} and [5E](#F5){ref-type="fig"}; DSE in EGTA: 95.88% ± 4.24%, n = 6, 1-way ANOVA, ACSF versus EGTA, F(2,18) = 19.21, p \< 0.001). Additionally, prior application of AM251 significantly reduced the magnitude of DSE, indicating that synapses onto PV(+)-INs undergo CB~1~R-dependent short-term plasticity facilitated by intracellular Ca^2+^ signaling ([Figures 5D](#F5){ref-type="fig"} and [5E](#F5){ref-type="fig"}; 86.14% ± 3.78%, n = 7, p = 0.007).

Increased intracellular Ca^2+^ signaling contributes to the induction of signaling events required for the expression of LTD ([@R34]; [@R9]; [@R6]). Given that eCBs regulate glutamatergic transmission onto PV(+)-INs in a CP-AMPAR-dependent manner, we hypothesized that CB~1~R activity underlies the expression of LFS-induced LTD at glutamatergic synapses onto PV(+)-INs. To investigate this mechanism, we examined the integrity of LTD in the presence of a CB~1~R inverse agonist, AM251 (5 μM). Preincubation of slices in AM251 blocked LFS-induced LTD and unmasked a small potentiation in EPSC amplitude ([Figures 5F](#F5){ref-type="fig"} and [5I](#F5){ref-type="fig"}; AM251, 113.26% ± 11.89%, n = 5, p = 0.002). If LTD at these synapses requires CB~1~R activity, then prior activation of CB~1~R with a CB~1/2~R agonist, WIN 55--212 (1 μM), should also occlude the expression of LTD. Indeed, continuous application of WIN 55--212 into the ACSF bath prevented the expression of LFS-LTD, strongly suggesting that CB~1~R activity mediates the expression of CP-AMPAR-dependent LTD at PV(+)-IN synapses ([Figures 5F](#F5){ref-type="fig"} and [5I](#F5){ref-type="fig"}; WIN, 92.70% ± 5.27%, n = 6, p = 0.002). To determine if CB~1~R activation alone is sufficient to induce LTD at PV(+)-IN synapses, we superfused WIN 55--212 into the ACSF bath followed by AM251. WIN 55--212 significantly decreased EPSC amplitude in PV(+)-INs that persisted in the presence of AM251, indicating that pharmacological activation of CB~1~R is sufficient to trigger LTD of glutamatergic transmission onto PV(+)-INs ([Figure 4G](#F4){ref-type="fig"}; WIN-AM251, 63.49% ± 5.49%, n = 5, p \< 0.001). Collectively, these data indicate that eCB signaling by CB~1~R mediates the expression of LTD triggered by CP AMPARs.

To investigate which eCB mediates LFS-LTD, we first examined the contribution of 2-AG by delivering LFS in slices treated with DO34. LFS-induced LTD remained completely intact in the presence of DO34, indicating that this plasticity does not require DAGL-synthesized 2-AG ([Figures 5H](#F5){ref-type="fig"} and [5I](#F5){ref-type="fig"}; LFS in DO34: 65.45% ± 5.69%, n = 4, p = 0.002). Interestingly, LFS delivered in slices preincubated in a FAAH inhibitor, URB597, failed to elicit LTD and often unmasked an enhancement in EPSC amplitude ([Figures 5H](#F5){ref-type="fig"} and [5I](#F5){ref-type="fig"}; 107.87% ± 14.17%, n = 9, p = 0.373). Given that AEA signaling mediates tonic CB~1~R function at this synapse, we speculated that inhibiting the degradation of AEA functionally occludes the expression of LFS-induced LTD. To test this hypothesis, we examined the sensitivity of glutamatergic transmission onto PV(+)-INs to DSE and WIN 55--212 in URB597-treated slices. URB597 blunted the expression of DSE and the magnitude with which WIN 55--212 decreased EPSC amplitude, indicating that preventing the degradation of AEA by FAAH likely increases functional CB~1~R occupancy, thereby preventing subsequent LTD induction with LFS ([Figures 4H](#F4){ref-type="fig"} and [4I](#F4){ref-type="fig"}) (DSE ACSF: 69.81% ±4.15%, n = 9; DSE URB: 83.75% ± 3.81%, n = 13, p = 0.028) (WIN URB: 77.44% ± 5.71%, n = 6, p\[versus ACSF\] = 0.020). Altogether, these data elucidate a mechanism wherein CB~1~R/CP-AMPAR LTD at synapses onto PV(+)-INs proceeds independently of 2-AG signaling and is heavily regulated by tonic AEA signaling.

DISCUSSION {#S8}
==========

We offer functional evidence that CP-AMPARs on PV(+)-INs within feedforward microcircuits dynamically regulate glutamatergic transmission in the NAc core through eCB signaling at CB~1~Rs. Using behavioral pharmacology and whole-cell patch-clamp electrophysiology in PV-IN and D1 MSN-specific transgenic reporter mice, we report that pharmacological blockade of CP-AMPARs in the NAc core increases locomotor output. Under basal conditions, CP-AMPARs are functionally restricted to glutamatergic synapses onto PV(+)-INs but not D1(+) or D1(−) MSNs. Ca^2+^ influx through CP-AMPARs at PV(+)-IN synapses is recruited during LFS to trigger eCB-dependent LTD. Additionally, we find that tonic eCB signaling at this synaptic locus is mediated by AEA and constitutively regulated by Ca^2+^ entry through CP-AMPARs. This study directly examines physiological processes governed by CP-AMPARs within PV-IN-embedded microcircuits in the NAc core.

CP-AMPARs in the NAc Constrain Locomotor Output and Are Functionally Restricted to PV-INs within Feedforward Microcircuits {#S9}
--------------------------------------------------------------------------------------------------------------------------

CP-AMPARs on MSNs have been implicated in the pathogenesis of both rewarding- and depressive-like behavioral pheno-types. However, a significant gap remains as to how CP-AM-PARs actually influence synaptic physiology in the NAc ([@R36]; [@R15]). We find that CP-AMPARs on PV(+)-INs contribute to the fast kinetics of AMPAR-mediated EPSCs detected at these synapses. Rapid detection of glutamatergic input, alongside the electrotonic transfer of charge along PV-IN dendrites, supports the unique role of PV-INs in disynaptic feedforward inhibition ([@R25]). As a synaptic intermediate between afferent-directed excitation of MSNs, PV-INs transduce shifts in corticolimbic circuit activity into feedforward GABAergic output. Thus, the biophysical properties of CP-AM-PARs may permit rapid integration of the same corticolimbic inputs driving NAc output.

The stoichiometric profile of AMPARs at glutamatergic synapses in the NAc has important implications for reward-related behavior ([@R5]; [@R8]; [@R36]; [@R2]). Withdrawal from repeated cocaine exposure leads to the progressive incorporation of GluA2-lacking CP-AMPARs on MSNs in a cell-type- and input-specific manner ([@R13]; [@R21]; [@R38]). Time-contingent adaptations at these synapses contribute to the "incubation of cocaine craving" that drives the reinstatement of reward-seeking behavior. In the present study, we provide additional functional evidence that CP-AMPARs are expressed basally at glutamatergic synapses onto PV(+)-INs but not D1(+) or D1(−) MSNs, consistent with prior assess ments of excitatory transmission in the NAc shell ([@R39]). Interestingly, we find that selectively targeting PV-IN activity by intra-NAc blockade of CP-AMPARs increases locomotor output in drug-naive mice. This finding invites the interpretation that excitatory inputs onto PV-INs constrains overall behavioral output, consistent with recent studies showing that (1) disabling PV-IN output decreases behavioral output during drug reward tasks and (2) CP-AMPAR blockade compromises feedforward inhibition of NAc shell MSNs ([@R37]; [@R39]; [@R33]). However, PV-INs may instead organize purposeful behavioral responses to salient environmental stimuli. For example, chemo- and opto-genetically silencing PV-IN activity in the NAc increases impulsivity in a 5-choice reaction time test ([@R22]). By reducing CP-AMPAR-mediated feedforward input onto PV-INs through CP-AMPARs, afferent inputs to the NAc may drive asynchronous MSN output, leading to enhanced locomotor activity. Future studies are needed to understand how excitatory transmission onto PV-INs programs functional MSN output to downstream limbic-motor centers.

CP-AMPARs Promote Tonic and Phasic eCB Signaling at PV-IN Synapses {#S10}
------------------------------------------------------------------

In the NAc core, stimulating glutamatergic inputs onto D1(−) MSNs for 5 min at 10 Hz results in LTD mediated by presynaptic CB~1~R and postsynaptic TRPV1 receptor function. AEA-induced TRPV1 activation results in Ca^2+^ and dynamin-dependent AMPAR endocytosis, whereas presynaptic CB~1~R activation results in a shift in the phosphorylation state of vesicular release proteins, such as RIM1α ([@R9]). Given that the same glutamatergic inputs onto MSNs collateralize onto synaptically connected PV-INs, we asked whether glutamatergic synapses onto PV-INs also undergo LFS-induced LTD. We initially hypothesized that LTD is unlikely to occur at these synapses, as the electrotonic properties of PV-IN dendrites rapidly transfer membrane potential shifts along the somatodendritic axis and the lack of a dendritic spines fails to confine intracellular effectors recruited during the induction and/or expression of LTD ([@R4]; [@R10]).

To our surprise, LFS recruits CP-AMPARs to induce robust LTD of glutamatergic transmission onto PV(+)-INs in the NAc core. CP-AMPARs expressed at discrete synapses throughout the limbic network have been associated with the expression of homeostatic and Hebbian plasticity mechanisms ([@R16]; [@R26]). A relatively unexplored question, however, is how CP-AMPARs define the molecular requirements for activity-dependent shifts in synaptic strength. We provide evidence that CP-AMPARs on PV(+)-INs trigger a form of LTD mediated by eCB signaling and authorize the release of tonic eCBs that act on presynaptic CB~1~R to regulate glutamate release probability. Indeed, LFS-induced LTD of glutamatergic transmission onto PV(+)-INs was absent following both CB~1~R blockade and activation. Several pieces of data point to AEA signaling over 2-AG as the principal eCB governing glutamatergic transmission at this synapse. First, disrupting 2-AG synthesis by inhibiting the Ca^2+^-sensitive enzyme DAGL had no significant effect on the magnitude of LTD or tonic CB~1~R activity. In contrast, increasing ambient AEA by blocking the activity of FAAH increased eCB tone, functionally occluded LTD, and significantly attenuated the effects of DSE and WIN 55--212 on glutamatergic transmission. Interestingly, blocking CB~1~R or inhibiting FAAH during the LFS induction protocol often potentiated EPSC amplitude. Although dissecting this observation is beyond the scope of this study, an intriguing hypothesis is that LFS-facilitated AEA release acts on TRPV1 receptors expressed at a subset of inputs onto PV-INs, leading to increased glutamate release probability ([@R3]). Collectively, our data support a mechanism wherein Ca^2+^ influx by CP-AMPARs is coupled to AEA signaling, which negatively regulates glutamatergic transmission onto PV(+)-INs.

Recent reports using an afferent-specific optogenetic approach indicate that fast-spiking, putative PV-INs in the NAc shell are more strongly innervated by corticolimbic inputs than MSNs, a finding that explains, in part, the high frequency of sEPSCs detected at PV(+)-IN synapses. The extensive innervation pattern of PV-INs necessitates greater regulatory control over the timing, strength, and synchronicity with which glutamatergic transmission drives PV-IN output. Accordingly, tonic AEA signaling by CB~1~R may serve as a gain-sorting mechanism ensuring appropriate input-output characteristics of NAc feedforward microcircuits. eCB release coupled to Ca^2+^ influx through CP-AMPARs may serve as an ideal gain-sensing element calibrating eCB tone to corticolimbic input. Although not tested directly, our findings also suggest that LFS increases eCB production beyond tonic levels, as AEA signaling contributes to both tonic and phasic CB~1~R activity. An activity-dependent rise in local eCB production has vast functional consequences on which glutamatergic inputs to the NAc are constrained by feedforward inhibition. Moreover, eCB-dependent neuromodulation at this synaptic locus, rather than at GABAergic PV-IN-to-MSN synapses, may serve as a substrate for adaptive reward learning ([@R35]).

A critical question posed by our data is whether the somatodendritic properties of glutamatergic synapses onto PV-INs differ across inputs. Indeed, CP-AMPAR blockade with NASPM blocked excitatory transmission by \~50%. Although a probable hypothesis is that CP-AMPARs are expressed on PV-INs alongside GluA2-containing Ca^2+^-impermeable AMPARs, an alternative possibility is that CP-AMPARs are enriched at distinct inputs. Inputs with greater innervation ratios relative to MSNs, for example, may possess distinct synaptic properties that differentially drive feedforward inhibition. Thus, superfusion of NASPM may serve as a pharmacological means to isolate CP-AMPAR-poor synapses onto PV-INs. Despite the prospect of inputs with distinct stoichiometric profiles of AMPARs, our data support a cohesive model of plasticity in which CPAMPAR- and CB~1~R-dependent LTD are elicited by LFS at overlapping synapses. Ongoing efforts are required to characterize afferent-specific differences in feedforward microcircuit function and how these properties regulate reward-related behavior.

Conclusions {#S11}
===========

PV(+)-INs in the NAc are fast-spiking GABAergic neurons embedded within a feedforward inhibitory network that coordinates functional NAc circuit output. We report that PV(+)-INs, unlike D1(+) an D1(−) MSNs, are enriched in GluA2-lacking CP-AMPARs that confer specialized synaptic properties to feedforward glutamatergic synapses. Importantly, we find that Ca^2+^ influx through CP-AMPARs triggers (1) eCB-dependent LTD by presynaptic CB~1~R and (2) tonic eCB signaling by retrograde AEA signaling. These findings provide functional evidence that CP-AMPARs are linked to the release of eCBs that gate tonic-and phasic-dependent shifts in glutamatergic synaptic strength. Understanding how CP-AMPARs contribute to synaptic function may lead to the development of therapeutic tools targeting IN microcircuits for the treatment of maladaptive motivational states, such as addiction and depression.

STAR★METHODS {#S12}
============

RESOURCE AVAILABILITY {#S13}
---------------------

### Lead Contact {#S14}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Brad Grueter (<brad.grueter@vumc.org>).

### Materials Availability {#S15}

This study did not generate new unique reagents.

### Data and Code Availability {#S16}

Raw electrophysiological traces and behavior videos have not been deposited in a public repository but are available upon request. No custom code was developed.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S17}
--------------------------------------

### Mice {#S18}

Mice were bred and housed at Vanderbilt University Medical Center in accordance with IACUC. Male mice 8--16 weeks of age were used for all electrophysiological and *in vivo* experiments. Experimental mice were housed in groups of 3--5/cage on a 12-hr light-dark cycle with *ad lib* access to standard food and water. Breeding cages were given 5LOD chow (PicoLab ®, 28.7% protein, 13.4% fat, 57.9% carbohydrate) to improve litter viability. For all electrophysiological experiments examining PV(+)-INs, Cre-induced STOP^*fl/fl*^-tdTomato mice (Ai9, *Gt(ROSA)26Sor*^*tm9(CAG-tdTomato)Hze*^) obtained from Jackson Laboratory (Stock No.: 007909) were crossed with PV-IRES-Cre (PV^Cre^, *Pvalb*^*tm1(cre)Arbr/J*^, Stock No.: 008069), generating PV^Cre^-tdTomato^fl/fl^ (PV^tdT^) mice. For all experiments examining D1 and D2 MSN physiology, C57BL/6J mice were bred to harbor a bacterial artificial chromosome (BAC) carrying the tdTomato fluorophore under control of the *Drd1a* (D1 receptor) promoter. In a subset of experiments, PV^tdT^ mice received either a single home cage injection of saline or cocaine HCl (15 mg/kg) administered intraperitoneal (IP).

METHOD DETAILS {#S19}
--------------

### Electrophysiology {#S20}

Whole-cell patch-clamp electrophysiological recordings were obtained in acute brain slice preparations from PV^tdT^ and D1tdTomato BAC transgenic mice. Mice were euthanized under isoflurane anesthesia after which parasagittal slices (250 μM) containing the NAc core were prepared from whole brain tissue using a Leica Vibratome in oxygenated (95% O2; 5%CO2) ice-cold *N*-methyl-*D*-glucamine (NMDG)-based solution (in mM: 2.5 KCl, 20 HEPES, 1.2 NaH~2~PO~4~, 25 Glucose, 93 NMDG, 30 NaHCO~3~, 5.0 sodium ascorbate, 3.0 sodium pyruvate, 10 MgCl~2~, and 0.5cCaCl~2~-2H~2~O). Slices were then recovered in NMDG-based recovery solution for 10--15-min at 30--32c°C before being transferred to a chamber containing artificial cerebral spinal fluid (ACSF, in mM: 119 NaCl, 2.5 KCl, 1.3 MgCl~2~-6H~2~O, 2.5 CaCl~2~-2H~2~O, 1.0 NaH~2~PO4-H~2~O, 26.2 NaHCO~3~, and 11cglucose; 287--295 mOsm). All experiments were performed using a Scientifica Slicescope Pro System with continuously perfused 28--32°C ACSF at 2cmL/min. PV-INs or MSNs in the NAc core were visualized using Scientifica PatchVision software and patched with 3--6 MΩ recording pipettes. (P1000 Micropipette Puller). For current-clamp recordings, experiments were performed in K^+^-based intracellular solution: (in mM: 135 K^+^-gluconate, 5 NaCl, 2 MgCl~2~, 10 HEPES, 0.6 EGTA, 3 Na~2~ATP, 0.4 Na~2~GTP; 290 mOsm). For voltage-clamp recordings, a Cs^+^-based intracellular solution was used (in mM: 120 CsMeSO~3~, 15 CsCl, 8 NaCl, 10 HEPES, 0.2 EGTA, 10 TEA-Cl, 4.0 Mg-ATP, 0.3 Na-GTP, 0.1 spermine, and 5.0c QX 314 bromide). In PV^tdT^ or D1tdTomato mice, PV(+)-INs and D1(+) and D1(−) (putative D2) MSNs were differentiated according to the expression of the red tdTomato fluorophore via 530 nm LED light. D1(−) MSNs were distinguished from interneuron cell types based on morphological (size, shape) and biophysical properties (e.g., capacitance, membrane resistance, and AMPAR decay kinetics).

For *voltage-clamp* recordings, electrically evoked excitatory postsynaptic currents (eEPSCs) were obtained at a command voltage of −70 mV and isolated by incorporating GABA~A~R antagonist, picrotoxin (PTX, 50cμM), into the ACSF bath. To obtain the current-voltage (I-V) function of AMPAR-mediated EPSCs, AMPAR-mediated EPSCs were isolated by also including NMDAR antagonist, APV (50cμM), into the ACSF bath, though NMDAR-mediated EPSCs contribute minimally to EPSC amplitude at −70 mV. EPSC decay kinetics were obtain from *t*~*1/2*~ obtained time, T, following peak EPSC amplitude. In experiments examining local glutamatergic transmission, a bipolar electrode was placed at the corticoaccumbens interface and stimulated at 0.1 Hz. Paired pulse ratios (PPR) were obtained within-experiment by delivering two 0.3-ms duration pulses with a 50-ms interstimulus interval and calculating the amplitude ratio of the second eEPSC to the first eEPSC (eEPSC~2~/eEPSC~1~) at the indicated time-point. sEPSC analysis was performed with Clampfit 10.4 using a stringent best-fit template obtained from preliminary 10-min recording bouts in D1(+) and D1(−) MSNs. Each recording bout yielded a rise/day time (≤3-ms) and amplitude (≥5 pA) selection criteria that was reflected in the overall template score. For *current-clamp* recordings, cells were permitted 5-min after entering whole-cell configuration to equilibrate to the intracellular dialysate, after which a depolarizing plateau potential was established to maintain cells at approximately −70 mV. To assess intrinsic membrane excitability, action potentials (APs) were elicited in PV(+)-INs or MSNs following −50 pA current steps increasing from 400 to 400 pA with an 800-ms step duration. Membrane resistance and series resistance (R~S~) were monitored continuously during all experiments, with \>20% change in R~S~ resulting in the omission of that experiment.

### Behavior {#S21}

For microinfusion studies, bilateral guide cannulas (26 gauge, cut to 3mm length, 2mm center to center distance, C235GS-5--2.0/ SPC- Plastics One, 22 Roanoke VA) were implanted above the NAc core (AP: 1.45, ML: ± 1.00, DV: 3.00). Infusion guides were secured into place using dental cement and then fitted with a dummy cannula (C235DCS-5/SPC, Plastics One, Roanoke VA) and dust cap (303DC/1 Plastics One, Roanoke VA). Animals were allowed to recover for at least 5 days before habituation for behavioral assay.

Animals were habituated to handling for 3 consecutive days in which they were restrained for increasing amounts of time (30 s, 60 s, 120 s). The following 2 consecutive days, animals were restrained for 120 s to mimic time required to perform infusion and then habituated to activity chambers for 1h (ENV-510; Med Associates). On test day, a bilateral infusion cannula (4mm cut length; C235IS-5/SPC, Plastics One, Roanoke VA) was connected to a 1 uL syringe (\#7001, Hamilton Company, Reno, NV) by polyethylene tubing (0.46 mm in diameter; Plastics One). NASPM was microinfused at a dose of 0 (saline) or 8 μg/ml at a rate of 0.25 μL per hemisphere over 60 s and was allowed to absorb for 60 s before cannula was slowly removed (PMID: 31874107). Animals were immediately placed into activity chambers for assessment of basal locomotor activity.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S22}
---------------------------------------

### Data analysis {#S23}

Electrophysiological experiments were analyzed using Clampfit 10.4 and GraphPad Prism v7.0. Changes in baseline EPSC amplitude, coefficient of variance (CV), and PPR were calculated by comparing mean values during 5cmin intervals specified in each time-course to baseline PPR and CV values. A depression was defined as a significant difference in eEPSC amplitude from baseline calculated during the time interval specified in the recording. After obtaining each dataset, Shapiro-Wilk tests were performed to assess normality. Data depicted in Figures were determined to be normally distributed. Thus, paired or unpaired t tests were used to analyze statistical differences between datasets. Sidak's post hoc analyses were used for analyses requiring multiple comparisons. Power analyses were performed with preliminary data during the acquisition of each new dataset. The sample size obtained from each power analysis calculation was then compared to sample sizes reported in the literature for similar experiments. Errors bars depicted in figures represent SEM. For all analyses, α was set as 0.05, with p values \< α indicating a statistically significant difference.

ADDITIONAL RESOURCES {#S24}
--------------------

No unpublished custom code, software, or algorithm was generated in this study.
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![CP-AMPARs Are Expressed Basally at Glutamatergic Synapses onto PV(+)-INs in the NAc Core\
(A) Schematic depicting transgenic reporter strategy and electrophysiological configuration within feedforward microcircuitry. D1(+) MSNs, black-filled circles; D1(−) MSNs, open circles; PV(+)-INs, pink-filled circles.\
(B) Representative traces of APs elicited in PV(+), D1(+), and D1(−) cells after a 350-pA somatic current injection. Scale bar: 50 mV/100 ms.\
(C) Representative AMPAR-mediated EPSCs in PV(+), D1(+), and D1(−) cells when voltage clamped at −70, 0, +20, and +40 mV. Scale bars: 100 pA/50 ms.\
(D and E) AMPAR I-V relationship (D) and RI quantified (E) in PV(+), D1(+), and D1(−) cells.\
(F) Average AMPAR:NMDAR ratios obtained from PV(+), D1(+), and D1(−) cells showing no difference between cell types.\
(G) Representative traces of EPSCs obtained from PV(+), D1(+), and D1(−) cells at baseline and in the presence of NASPM. Scale bars: 50 pA/50 ms.\
(H) Time course summary of normalized EPSC amplitude and Quantification of average EPSC amplitude at PV(+), D1(+), and D1(−) synapses during NASPM bath application.\
(I) Decay t~1/2~ of EPSCs at −70 mV in PV(+), D1(+), and D1(−) cells showing differences in AMPAR decay kinetics and the contribution of CP-AMPARs.\
(J) Representative traces of sEPSCs in PV(+), D1(+), and D1(−) cells.\
(K) Average sEPSC frequency in PV(+), D1(+), and D1(−) cells over a 5-min recording period. Scale bar: 20 pA/60 s.\
(L) Average sEPSC amplitude in PV(+), D1(+), and D1(−) cells over a 5-min recording period. Error bars indicate SEM. \*p \< 0.05.](nihms-1616083-f0002){#F1}

![CP-AMPAR Blockade in the NAc Core Increases Locomotor Output\
(A) Schematic depicting cannulated delivery of saline (SAL; black) or NASPM into the NAc core prior to a 30-min open-field task.\
(B) Locomotor activity in NASPM (pink-filled circles)- and SAL (black-filled circles)-infused mice binned every 5 min showing that NASPM increases locomotor output.\
(C) Total locomotor activity averaged over the 30-min OFA with NASPM (pink-filled bars)-infused mice exhibiting increased locomotor output than SAL (black-filled bar)-infused mice. Error bars indicate SEM. \*p \< 0.05.](nihms-1616083-f0003){#F2}

![LFS Triggers Ca^2+^ and CP-AMPAR-Dependent LTD of Glutamatergic Transmission onto PV(+)-INs\
(A) Schematic depicting PV^tdTom^ transgenic reporter strategy and electrophysiological configuration within feedforward microcircuitry. Note that all experiments were performed in the dorsomedial NAc core near the corticoaccumbens interface. Scale bar for all panels: 50 pA/50 ms.\
(B) Representative traces of high-fidelity EPSCs recorded from PV(+) during the 10-Hz LFS induction protocol.\
(C) Representative traces and experiment in PV(+)-INs at baseline and post-LFS showing that LFS induces robust LTD of glutamatergic transmission.\
(D) Time course summary of normalized EPSCs in PV(+)-INs during LFS recording period.\
(E) Representative EPSCs and normalized time-course summary of LFS-induced LTD assessed with a Ca^2+^ chelator, BAPTA, included in the internal solution.\
(F) Representative EPSCs and normalized time course of LFS-induced LTD assessed in the presence of a pan-mGluR antagonist, LY341495.\
(G) Representative EPSCs and normalized time course summary showing that group I mGluR agonist, (*RS*)-DHPG, fails to elicit LTD at synapses onto PV(+)-INs.\
(H) Quantification of normalized EPSC amplitude post-LFS t(gray) (35--40) min in ACSF, LY341495, and BAPTA and average EPSC amplitude post-DHPG.\
(I) Representative EPSCs and normalized time course summary of LFS-induced LTD assessed in the presence of an NMDAR antagonist, APV.\
(J) Representative EPSCs and normalized time course of LFS-induced LTD assessed in the presence of NASPM.\
(K) Quantification of normalized EPSC amplitude post-LFS t(gray) (35--40) min in APV and NASPM. ACSF average depicts the same data in (H). Error bars indicate SEM. \*p \< 0.05.](nihms-1616083-f0004){#F3}

![CP-AMPARs Gate Tonic eCB Signaling through CB~1~Rs at Glutamatergic Synapses onto PV(+)-INs\
Gray-shaded region highlights the amplitude difference between EPSC~1~ and EPSC~2~ of the paired pulses during 50-ms paired-pulse stimulation. All traces scaled to have comparable EPSC~1~ amplitudes.\
(A) Representative traces of 50-ms paired-pulse EPSCs obtained from PV(+)-INs in ACSF (black)- and NASPM (maroon)-incubated slices. Scale bars: 50 pA/50 ms.\
(B and C) Quantification of average PPR (B) and CV (C) obtained from PV(+)-INs in ACSF versus NASPM.\
(D) Representative traces of 50-ms paired-pulse EPSCs obtained from PV(+)-INs in slices incubated in AM251 (pink), AM251 + NASPM (light pink), URB597 (gray), and DO34 (light gray). Scale bars for all traces: 50 pA/50 ms.\
(E) Average PPR following each pharmacological manipulation. Dotted line corresponds to average EPSC amplitude plotted for visual and statistical purposes.\
(F) Left y axis: normalized time course summary of average EPSC amplitude in PV(+)-INs during bath application of AM251. Right y axis: raw PPR time course during AM251 superfusion (open circles).\
(G) Normalized time course summary of average EPSC amplitude during AM251 bath application in slices incubated and continuously perfused with URB597 (pink-filled circles) or NASPM (open circles).\
(H) Normalized time course summary of EPSC amplitude during acute bath application of DO34.\
(I) Quantification of average EPSC amplitude following each pharmacological manipulation. Error bars indicate SEM. \*p \< 0.05.](nihms-1616083-f0005){#F4}

![CB~1~R Signaling Mediates the Expression of LTD Triggered by CP-AMPARs at Glutamatergic Synapses onto PV(+)-INs\
All scale bars: 50 pA/50 ms.\
(A) Schematic depicting retrograde eCB signaling at glutamatergic synapses onto PV-INs.\
(B) Representative DSE experiment performed in triplicate for each PV(+)-IN with EPSC sampling rate increased to 0.2 Hz.\
(C) Top: representative traces of EPSCs obtained pre- and post-DSE in ACSF. Bottom: time course summary of normalized EPSCs obtained from PV(+)-INs during DSE experiment performed in ACSF.\
(D) Top: representative traces of EPSCs obtained pre- and post-DSE in AM251 (black circle) and EGTA-containing internal solution (pink open circle). Bottom: time course summary of normalized EPSCs obtained from PV(+)-INs during DSE experiment performed in AM251 (black circles) and EGTA (pink open circles).\
(E) Quantification of average EPSC amplitude post-DSE following each pharmacological manipulation.\
(F) Representative traces and normalized time course summary of EPSCs obtained from PV(+)-INs pre- and post-LFS in AM251 (top, pink-filled circles) and WIN 55--12 (bottom, pink open circles).\
(G) Representative traces and normalized time course summary of EPSCs obtained from PV(+)-INs at baseline, following WIN 55--212 application and in AM251.\
(H) Quantification of EPSCs during WIN 55--212 and AM251 bath application.\
(I) Representative traces and normalized time course summary of EPSCs obtained from PV(+)-INs pre- and post-LFS in URB597 (pink-filled circles) and DO34 (open circles).\
(J) Average EPSC amplitude post-LFS following each pharmacological treatment.\
(K) Normalized time-course summary of EPSCs obtained from PV(+)-INs during WIN 55--212 superfusion in slices incubated in URB497. Gray-shaded summary depicts control WIN 55--212 experiments performed in (G).\
(L) Time course summary of normalized EPSCs obtained from PV(+)-INs during DSE experiments repeated in ACSF- and in URB597-incubated slices. Error bars indicate SEM. \*p \< 0.05.](nihms-1616083-f0006){#F5}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                        SOURCE                                                            IDENTIFIER
  ---------------------------------------------------------- ----------------------------------------------------------------- -----------------------------------------------------------
  Chemicals, Peptides, and Recombinant ProteinsPubchem CID                                                                     
  1-Naphthyl acetyl spermine (NASPM) trihydrochloride        Sigma-Aldrich, St. Louis, MO                                      16219727
  WIN 55,212--2 mesylate                                     Tocris/Bio-Techne, Minneapolis, MN                                6604176
  AM251                                                      Tocris/Bio-Techne, Minneapolis, MN                                2125
  Picrotoxin                                                 Sigma-Aldrich, St. Louis, MO                                      31304
  NBQX disodium salt                                         Tocris/Bio-Techne, Minneapolis, MN                                6098006
  LY341495                                                   Tocris/Bio-Techne, Minneapolis, MN                                9819927
  (RS)-DHPG                                                  Tocris/Bio-Techne, Minneapolis, MN                                108001
  BAPTA                                                      Tocris/Bio-Techne, Minneapolis, MN                                104751
  EGTA                                                       Tocris/Bio-Techne, Minneapolis, MN                                6207
  DO-34                                                      Glixx Laboratories                                                GLXC-09757
  D-AP5                                                      Tocris/Bio-Techne, Minneapolis, MN                                135342
  Experimental Models: Organisms/Strains                                                                                       
  B6.Cg-Pvalb-T2A-Cre-D                                      The Jackson Laboratory, Sacramento, CA                            Stock No: 022863
  Mouse: B6.Cg-Tg(Drd1a-tdTomato) 6Calak/J                   The Jackson Laboratory, Sacramento, CA                            Stock No: 016204
  Mouse: B6.Cg-*Gt(ROSA)26Sor*^*tm9(CAG-tdTomato)Hze*^/J     The Jackson Laboratory, Sacramento, CA                            Stock No: 007909
  Software and Algorithms                                                                                                      
  pClamp 10                                                  Molecular Devices, 1311 Orleans Drive, Sunnyvale, CA              <http://www.moleculardevices.com>
  EthoVision XT                                              Noldus Information Technology, Leesburg, VA                       <http://www.noldus.com>
  Prism                                                      GraphPad Software, Inc. 7825 Fay Avenue, Suite 230 La Jolla, CA   <https://www.graphpad.com:443/scientific-software/prism/>

###### Highlights

-   Synapses onto PV-INs in the NAc core express Ca^2+^-permeable AMPA receptors (CP-AMPARs)

-   Ca^2+^ influx through CP-AMPARs on PV-INs triggers long-term depression mediated by CB~1~ receptors

-   CP-AMPARs promote tonic endocannabinoid signaling, inhibiting glutamate release

-   Blockade of CP-AMPARs in the NAc core disinhibits locomotor output
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